Amplia Therapeutics Limited Stock
Stocks
ATX
AU0000023822
Biotechnology & Medical Research
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1400 AUD | +3.70% |
|
+3.70% | -6.67% |
| Market Cap | 69.3M 48.31M 42.49M 39.47M 36.3M 68.08M 4.68B 472M 184M 2.28B 181M 177M 7.92B | P/E 2027 * |
-5.87x | P/E 2028 * | -22.5x |
|---|---|---|---|---|---|
| Enterprise Value | 53.8M 37.5M 32.98M 30.64M 28.18M 52.85M 3.63B 366M 143M 1.77B 141M 138M 6.15B | EV / Sales 2027 * |
-
| EV / Sales 2028 * | 4.78x |
| Free-Float |
90.48% | Yield 2027 * |
-
| Yield 2028 * | - |
| 1 day | +3.70% | ||
| 1 week | +3.70% | ||
| Current month | -3.45% | ||
| 1 month | +12.00% | ||
| 3 months | -15.15% | ||
| Current year | -6.67% |
| 1 week | 0.14 |  | 0.14 |
| 1 month | 0.12 | | 0.16 |
| Current year | 0.1 | | 0.28 |
| 1 year | 0.1 | | 0.28 |
| 3 years | 0.05 | | 0.42 |
| 5 years | 0.05 | | 0.42 |
| 10 years | 0.04 | | 18.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 2022-12-04 | |
Hamish George
DFI | Director of Finance/CFO | - | 2021-09-30 |
Jason Lickliter
CTO | Chief Tech/Sci/R&D Officer | - | 2025-05-11 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Peach
BRD | Director/Board Member | 70 | 2015-09-01 |
Warwick Tong
CHM | Chairman | - | 2018-05-24 |
| Director/Board Member | - | 2018-05-03 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 9/8/25 | Buy | Founder | 86,957 | 0.0224% | ||
| 9/8/25 | Buy | Director | 652,174 | 0.1681% | ||
| 9/8/25 | Fiscal year | Chairman | 750,000 | 0.1933% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.70% | +3.70% | -47.17% | +64.71% | 48.49M | |
| +1.23% | +0.35% | +51.62% | +87.98% | 55.27B | |
| +5.09% | +6.24% | +63.15% | +62.06% | 54.15B | |
| +0.72% | -0.05% | +3.84% | +409.54% | 23.11B | |
| +0.25% | +0.55% | -19.67% | -15.22% | 23.22B | |
| -0.71% | +5.19% | +30.32% | -4.07% | 20.33B | |
| -0.37% | +0.71% | +31.36% | -31.61% | 17.91B | |
| -0.96% | +5.98% | +32.93% | +545.99% | 15.76B | |
| -2.54% | -8.73% | +164.11% | +289.45% | 15B | |
| +1.22% | -0.05% | +22.58% | +182.63% | 13.82B | |
| Average | +0.73% | +0.64% | +33.31% | +159.14% | 23.86B | |
| Weighted average by Cap. | +1.27% | +2.77% | +43.47% | +134.78% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | - | 10M 6.97M 6.13M 5.7M 5.24M 9.82M 675M 68.11M 26.57M 329M 26.17M 25.6M 1.14B |
| Net income | -11.6M -8.09M -7.11M -6.61M -6.08M -11.4M -783M -79.01M -30.82M -382M -30.36M -29.7M -1.33B | -3.6M -2.51M -2.21M -2.05M -1.89M -3.54M -243M -24.52M -9.56M -119M -9.42M -9.22M -411M |
| Net Debt | -15.5M -10.81M -9.5M -8.83M -8.12M -15.23M -1.05B -106M -41.18M -510M -40.56M -39.69M -1.77B | -21.5M -14.99M -13.18M -12.25M -11.26M -21.12M -1.45B -146M -57.12M -708M -56.27M -55.05M -2.46B |
Employees
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-23 | A$0.1400 | +3.70% | 110,185 |
| 26-07-23 | A$0.1350 | 0.00% | 799,013 |
| 26-07-22 | A$0.1350 | -3.57% | 1,053,005 |
| 26-07-21 | A$0.1400 | 0.00% | 290,931 |
| 26-07-20 | A$0.1400 | +3.70% | 46,798 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.1350AUD
Average target price
0.4200AUD
Spread / Average Target
+211.11%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ATX Stock
Select your edition
All financial news and data tailored to specific country editions
